Related Experiment Video
Updated: Jun 6, 2026
10:26
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Deep vein thrombosis: review and update.
Ashutosh Niranjan1, Nivesh Agarwal, Tarun Agarwal
1Department of Surgery, Subharti Medical College, Meerut 250002.
Journal of the Indian Medical Association
|December 1, 2010
Summary
Deep vein thrombosis (DVT) is a serious condition complicating surgery. Newer imaging and treatments like low molecular weight heparin improve patient outcomes and reduce bleeding risks.
Area of Science:
- Vascular Medicine
- Thrombosis Research
- Medical Imaging
Background:
- Deep vein thrombosis (DVT) is a prevalent and severe complication in surgical patients, often linked to identifiable or hidden risk factors.
- The underlying mechanisms of lower extremity blood clot formation are better understood due to advancements in diagnostic investigations.
- Pulmonary embolism (PE) is a primary early complication of DVT, with postphlebitic syndrome and recurrent DVT posing significant long-term risks.
Purpose of the Study:
- To highlight the importance of accurate patient risk evaluation for deep vein thrombosis.
- To emphasize the necessity of appropriate management strategies for DVT.
- To discuss advancements in diagnostic imaging and therapeutic interventions for DVT.
Main Methods:
- Utilizing newer imaging techniques for enhanced evaluation of the peripheral venous system.
- Reviewing the impact of advancements in understanding DVT pathophysiology.
- Assessing the role of low molecular weight heparin in managing DVT and its complications.
Main Results:
- Newer imaging modalities provide unprecedented insights into the peripheral venous system.
- The risk of pulmonary embolism and postphlebitic syndrome increases with recurrent DVT.
- Low molecular weight heparin has demonstrated a reduction in the incidence of postheparin bleeding.
Conclusions:
- Accurate identification of high-risk patients and effective management are crucial for mitigating DVT complications.
- Advancements in diagnostic and therapeutic options have improved the outlook for surgical patients at risk of DVT.
- Low molecular weight heparin represents a safer therapeutic option, reducing bleeding complications.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...